NuVasive(R) to Exhibit Innovative Products and Procedures at AANS 2013

NuVasive(R) to Exhibit Innovative Products and Procedures at AANS 2013 
SAN DIEGO, CA -- (Marketwired) -- 04/11/13 --  NuVasive, Inc.
(NASDAQ: NUVA), a medical device company focused on developing
minimally disruptive surgical products and procedures for the spine,
is excited to announce their participation at the 81st American
Association of Neurological Surgeons (AANS) Scientific Meeting from
Saturday, April 27th, to Wednesday, May 1st, 2013, in booth #1845 at
the Ernest N. Morial Convention Center in New Orleans, LA. 
With over 3,000 neurosurgeons and healthcare professionals expected
to attend, this year's theme is "changing our culture to advance
patient safety." NuVasive will demonstrate a comprehensive spine
portfolio featuring several of our newest game changers, including
the VuePoint(R) II OCT System and the PCM(R) Cervical Disc. 
"As a global medical device company, we look forward to partnering
with AANS to further superior outcomes and patient safety with our
newest game changing products," said Alex Lukianov, Chairman and CEO
of NuVasive. "As an XLIF(R) patient myself, I know firsthand the
safety concerns of most patients about to be treated with invasive
surgery. Since NuVasive has redefined spine surgery with a
revolutionary minimally disruptive approach, patients no longer have
to undergo invasive spine procedures. Patients are often able to walk
the same day of surgery, experience less blood loss, and spend less
time in the hospital which helps patient's recover quickly and
safely. We are very excited to participate at AANS to showcase XLIF
and our entire portfolio of solutions for the spine." 
AANS will host several leaders who pioneered the patient safety
movement, including Donald Berwick, MD, former administrator of the
Center of Medicare and Medicaid Services and Carolyn Clancy, MD,
Director of the Agency for Healthcare Research and Quality (AHRQ).  
NuVasive is scheduled to participate in the following events at AANS: 


 
--  NuVasive(R)Exhibit Booth #1845: The NuVasive exhibit booth will
    feature a number of innovative, minimally disruptive products and
    procedures including: XLIF(R), MAS(R) TLIF, MAS(R) PLIF,
    ALIF, ILIF(R), Precept(TM), PCM(R) Cervical Disc, Biologics,
    and our NVM5(R) neuromonitoring system.
    
    
--  AANS Practical Courses (labs): NuVasive will participate in practical
    courses on Saturday, April 27th and Sunday, April 28th. The courses
    include extensive, hands-on offerings. Please visit
    http://budurl.com/AANSPracticalCourses for more details.
    
    
--  Clinical Papers: Numerous invited podium presentations and entire
    sections of the AANS scientific program will be dedicated to lateral
    approach surgery with an emphasis on XLIF(R) for both basic and
    advanced applications.

  
For more information on AANS 2013 please visit: http://Ez.com/AANS2013  
For NuVasive Press Materials please visit:
http://www.nuvasive.com/about-us/newsroom/  
About AANS 
 The American Association of Neurological Surgeons (AANS)
is the organization that speaks for all of neurosurgery. The AANS is
dedicated to advancing the specialty of neurological surgery in order
to promote the highest quality of patient care. 
About NuVasive
 NuVasive is a medical device company focused on
developing minimally disruptive surgical products and procedurally
integrated solutions for the spine. The Company is the 4th largest
player in the $8.2 billion global spine market. NuVasive's principal
product offering is based on its Maximum Access Surgery, or MAS(R)
platform. The MAS platform combines several categories of solutions
that collectively minimize soft tissue disruption during spine
surgery with maximum visualization and safe, easy reproducibility for
the surgeon: a proprietary software-driven nerve avoidance system and
intra-operative monitoring support; MaXcess(R), a unique split-blade
retractor system; a wide variety of specialized implants; and several
biologic products to aid in the spinal fusion process. MAS
significantly reduces surgery time and returns patients to activities
of daily living much faster than conventional approaches. Having
redefined spine surgery with the MAS platform's lateral approach,
known as eXtreme Lateral Interbody Fusion, or XLIF(R), NuVasive has
built an entire spine franchise. With over 80 products today spanning
lumbar, thoracic and cervical applications, the Company will continue
to expand and evolve its offering predicated on its R&D focus and
dedication to outstanding service levels supported by a culture of
Absolute Responsiveness(R).  
NuVasive cautions you that statements included in this press release
that are not a description of historical facts are forward-looking
statements that involve risks, uncertainties, assumptions and other
factors which, if they do not materialize or prove correct, could
cause NuVasive's results to differ materially from historical results
or those expressed or implied by such forward-looking statements. The
potential risks and uncertainties are described in NuVasive's press
releases and periodic filings with the Securities and Exchange
Commission. NuVasive's public filings with the Securities and
Exchange Commission are available at www.sec.gov. NuVasive assumes no
obligation to update any forward-looking statement to reflect events
or circumstances arising after the date on which it was made.  
Investor Contact:
Stephan Ogilvie 
VP, Corporate Development & Investor Relations
NuVasive, Inc.
201-322-6515
investorrelations@nuvasive.com  
Media: 
Nicole Collins
NuVasive, Inc.
858-909-1907
media@nuvasive.com 
 
 
Press spacebar to pause and continue. Press esc to stop.